Skip to content

uniQure QURE Income Tax

Income Tax at other companies

Precigen logo
PrecigenPGEN
$0
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$0-100%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$347K-99.5%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$839K-24.3%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$5.51M-29.9%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
$46K+107%

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's income tax?
uniQure (QURE) reported income tax of $488K in Q1 2026.
How has uniQure's income tax changed year-over-year?
uniQure's income tax decreased by 1.6% year-over-year, from $496K to $488K.
What is the long-term trend for uniQure's income tax?
Over 2 years (2022 to 2024), uniQure's income tax has grown at a 28.5% compound annual growth rate (CAGR), from -$1.47M to $2.43M.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.